Vimarsana
Biggest News Aggregation in the World

Page 33 - Volution Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Volution Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Volution Group Today - Breaking & Trending Today

Volution inks two European acquisitions for an initial EUR35 million - Vimarsana News

Volution inks two European acquisitions for an initial EUR35 million

Volution Group PLC on Thursday celebrated its strengthened presence in European markets, after signing two acquisition deals in Slovenia, Croatia, and France. Volution is a West Sussex, England-based... | April 20, 2023

Volution in Slovenia, France acquisitions for up to €55m - Vimarsana News

Volution in Slovenia, France acquisitions for up to €55m

Ventilation products maker Volution said it has bought I-Vent in Slovenia and completed the acquisition of Ventilairsec SA in France.

Volution acquires I-Vent in Slovenia, Croatia - Vimarsana News

Volution acquires I-Vent in Slovenia, Croatia

UK-based designer and manufacturer of energy efficient indoor air quality solutions Volution Group [LSE:FAN] said on Thursday that it has signed an agreeme

FTSE 250 movers: Vistry, Vivendum, Vesuivius unplugged as they go ex-div - Vimarsana News

FTSE 250 movers: Vistry, Vivendum, Vesuivius unplugged as they go ex-div

FTSE 250: 19,125.11, -75.74 (-0.39%).

Research Analysts' Updated EPS Estimates for April 13th (AAL, CKN, DEST, FAN, IHR, KMR, LSEG, NRR, NXR, OXIG) - Vimarsana News

Research Analysts' Updated EPS Estimates for April 13th (AAL, CKN, DEST, FAN, IHR, KMR, LSEG, NRR, NXR, OXIG)

Research Analysts’ updated eps estimates for Thursday, April 13th: Anglo American (LON:AAL) had its top pick rating reaffirmed by analysts at Citigroup Inc.. Clarkson (LON:CKN) had its neutral rating reiterated by analysts at JPMorgan Chase & Co.. The firm currently has a GBX 3,740 ($46.32) target price on the stock. Destiny Pharma (LON:DEST) had its […]

Source: wkrb13.com